Product information and disease descriptionProduct descriptionProduct informationPharmacology
Mechanism of action
6 evidence topics · 5 sources
Oncolytic immunotherapy with dual mechanisms of action
“Cretostimogene grenadenorepvec (hereafter, cretostimogene) is an oncolytic immunotherapy with dual mechanisms of action” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“it replicates in and lyses cancer cells with retinoblastoma-E2F pathway alterations and amplifies the immune response” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote